FOR SOUTH AFRICAN RESIDENTS
Sanofi
Antistax
  • Home
  • Contact
  • FAQ
  • About
    • Tablets Product Information Double Fresh Gel
  • Leg Conditions
    • what is CVI
  • Vein check
    • How Antistax® works
      • Red Vine Leaf Extract
    • FAQ

      Sitemap

      • About

        • Tablets Product Information Double Fresh Gel
      • Leg Conditions

        • what is CVI
      • Vein check

      • How Antistax® works

        • Red Vine Leaf Extract
      • FAQ

      back to top
      • Antistax®
      • South Africa
      • Sitemap
      • Privacy Policy

      • Terms of Use

      • Cookies

      • Print page
      Sanofi
      COPYRIGHT 2020 - Sanofi-Aventis South Africa (Pty) Limited - ALL RIGHTS RESERVED
      ANTISTAX® active leg tablets. Dry extract of red vine leaf AS 195 (4 - 6:1) 360 mg per tablet. ANTISTAX® Double Fresh Gel contains Red Vine Leaf Extract. Western herbal. This unregistered medicine has not been evaluated by the SAHPRA for its quality, safety or intended use. Applicant: sanofi-aventis south africa (pty) ltd, Reg. no.:1996/010381/07. Sanofi House, 2 Bond Street, Grand Central Ext. 1, Midrand, 1685. Tel: (011) 256 3700 Fax: (011) 256 3707. www.sanofi-aventis.com.

      References: 1. Antistax PIL 2. Antistax Double Fresh Gel PIL 3. Kiesewetter H. Koscielny J, Kalus U et al. Efficacy of orally administered extract of red vine leaf AS 195 (folia vitis viniferae) in chronic venous insufficiency (stages I-II): a randomised, double-blind, placebo-controlled trial. Arzneim.-Forsch./Drug Res 2000;50(1):109-117. 4. Kalus U, Koscielny J, Grigorov A et al. Improvement of cutaneous microcirculation and oxygen supply in patients with Chronic Venous Insufficiency by orally administered extract of red vine leaves AS 195: a randomised, double-blind, placebo-controlled, crossover study. Drugs R&D 2004; 5(2): 63-71. 5. Nees S, Weiss DR, Reichenblach-Klinke E et al. Protective Effects of Flavonoids Contained in the Red Vine Leaf on Venular Endothelium against the Attack of Activated Blood Components in vitro. Arzneim.-Forsch./Drug Res. 2003;53(5):330-341. 6. https://my.clevelandclinic.org/health/diseases/16872-chronic-venous-insufficiency-cvi/management-and-treatment (last accessed 20 February 2020) 7. Francoise Pitsch. Results of the DECIDE survey: appraisal of the predictive value for chronic venous disease of a symptom. Phlebolymphology Vol 18. No. 3. 2011 8. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406103/ (last accessed 24 Feb 2020) 9. The Epidemiology of Chronic Venous Insufficiency and Varicose Veins by Jennifer L. Beebe-Dimmer, John R Pfeifer, Jennifer S. Engle and David Schottenfeld. March 2005 SAZA.ANTI.19.08.0315

      Disclaimer

      You are about to visit an independent website for which SANOFI assumes no liability. Do you wish to proceed?

      This website uses cookies to track its audience and improve its content. By continuing to browse this website, you agree to the use of such cookies. Click here for more information on cookies.

      OK